IP Forum For Life Sciences

General Counsel Forum
November 11, 2017
Corporate Legal Operations Forum
February 10, 2018
Show all

IP Forum For Life Sciences

December 2–4, 2018 | The Langham Huntington | Pasadena, CA

Join like-minded Chief IP Counsel and other senior in-house counsel for inspiration and insight, networking and learning, and proven strategies to improve your business practices.

Faculty Members Include

  • DANIELLE ABRAMSON (RedHill Biopharma), Vice President, Intellectual Property & Research
  • GWILYM ATTWELL (Fish & Richardson P.C.), Principal
  • JAY BARRON (Corning Incorporated), Senior Intellectual Property Attorney
  • KELLIE BICKEL (TwinStrand Biosciences, Inc.), Director Of Intellectual Property
  • MICHELLE BOODEN (Salk Institute for Biological Studies), Strategic Liaison
  • HEATHER BOUSSIOS (Aptevo Therapeutics), Assistant General Counsel, Intellectual Property & Legal Department
  • BRYAN BOYLE (Alkahest), Senior Legal & Intellectual Property Counsel
  • MICHAEL BUNIS (Choate Hall & Stewart LLP), Practice Group Leader
  • JENNIFER BURDMAN (PolarityTE, Inc.), Chief IP Officer and Deputy General Counsel
  • JIM BUTLER (BioAtla LLC), Intellectual Property Counsel
  • JENNA CHANDHOK (Global Prior Art, Inc.), Group Leader, Chemistry & Materials
  • MARCIE B. CLARKE, Ph.D. (McCarter & English LLP), Partner, Intellectual Property
  • KRYS CORBETT (ORIC (Overcoming Resistance in Cancer)), General Counsel and Senior Director of Business Development
  • ROBERT COTTONE (OrbusNeich Medical Inc.), Vice President, Intellectual Property & Technologies
  • ROBERT DAILEY (Elevance Renewable Sciences, Inc.), Lead Intellectual Property Counsel
  • MICHAEL DEGN (MultiLing), Vice President, Sales
  • LAURA DEMOOR (Baxter Healthcare Corporation), Senior Intellectual Property Counsel
  • MARGARET DUNBAR (Synthetic Genomics), Vice President, Intellectual Property
  • TERRANCE FITZGERALD (Tolmar, Inc.), Senior Director, Intellectual Property Counsel
  • PATRICK FOGLE (Lonza), Global Head of Intellectual Property
  • ALYSON FULLER (Prolacta Bioscience), Vice President, Intellectual Property
  • MARSHA ROSE GILLENTINE (Sterne Kessler), Director
  • DOUG GOLIGHTLY (Emergent BioSolutions), Director, Intellectual Property
  • BRIGITTE HAJOS (REG Life Sciences, Inc.), Patent & Intellectual Property Strategist
  • COLIN HEITZMANN (Otsuka Pharmaceutical Development & Commercialization, Inc.), Senior Corporate Attorney, Senior Director
  • ELIZABETH HOWARD (Arbutus Biopharma, Inc.), Executive Vice President and General Counsel
  • MARK JACKSON (Editas Medicine), Senior Director, Intellectual Property
  • JENNIFER JOHNSON (Blaze Bioscience, Inc.), Head of Legal & Intellectual Property
  • DAVID JOYAL (Coty, Inc.), Vice President, Legal & Patents
  • TAMARA KALE (Genentech), Senior Patent Counsel
  • JOHN LABBE (Marshall, Gerstein & Borun), Partner
  • KAY LAWTON (Metabolon), Vice President, Intellectual Property
  • MICHELLE LEE (Five Prime Therapeutics), Senior Patent Counsel
  • ADAM LERNER (PTTGC Innovation America Corporation), Intellectual Property Attorney
  • AINSLIE LITTLE (BlueRock Therapeutics), Director of Intellectual Property
  • ADRIAN LOONEY (Pfizer), Vice President & Assistant General Counsel
  • DREW LOWERY (Global Prior Art, Inc.), Group Leader, Pharmaceuticals & Biotechnology
  • ADAM LUNCEFORD (Bayer U.S. LLC), Patent Attorney
  • JOSHUA MARCUS (Insmed Incorporated), Senior Counsel, Head of Intellectual Property
  • JANET MARTINEAU (Unity Biotechnology), Head of Intellectual Property
  • CHRISTINE MCCORMACK (Takeda), Associate General Counsel, Intellectual Property
  • AHMED MOUSA (Pieris Pharmaceuticals, Inc.), Vice President of Licensing, Intellectual Property, and Legal Affairs
  • MICHAEL MUELLER (Conatus Pharmaceuticals), Vice President, General Counsel & Secretary
  • DAVID PAULING (Sutro Biopharma, Inc), Executive Director, Legal Affairs
  • NEELA PAYKEL (Proteus Digital Health, Inc.), Vice President, Head of Legal Affairs & Compliance
  • MICHAEL PENN (Amgen), Principal Counsel, Intellectual Property & Litigation
  • DIANE RETALLACK (Pfenex, Inc.), Senior Director, Upstream Processing & Intellectual Property
  • JENNIFER RHODES (Adamas Pharmaceuticals, Inc.), Chief Business Officer, General Counsel, and Corporate Secretary
  • CHRISTY ROTHWELL (Bexion Pharmaceuticals, Inc.), Vice President, Legal & Intellectual Property
  • ELLEN SCORDINO (Cooley LLP), Partner
  • LALEH SHAYESTEH (University of California Berkeley), Senior Licensing Officer
  • DEBORAH M. SHELTON (McCarter & English LLP), Food & Drug Law Practice Group Leader
  • JONATHAN M. SPARKS, Ph.D. (McCarter & English LLP), Partner, Intellectual Property
  • ERIK SPEK (Vedanta Biosciences, Inc.), Vice President and Head of Intellectual Property
  • ERIC STEFFE (Sterne Kessler), Director
  • JOSEPH TAFFY (Thermo Fisher Scientific), Division Intellectual Property Counsel, Genetic Sciences
  • STACY TAYLOR (Adaptive Biotechnologies), Vice President, Intellectual Property
  • IMMAC THAMPOE (Regeneron Pharmaceuticals, Inc.), Executive Director & Assistant General Counsel, Intellectual Property Portfolio Development
  • JUSTIN UNDERWOOD (Spectrum Pharmaceuticals, Inc.), Associate General Counsel, Intellectual Property, Regulatory & Commercial
  • JULIE URVATER (Immune Design), Director of Intellectual Property
  • SHELBY WALKER (CRISPR Therapeutics), Vice President, Head of Intellectual Property
  • BRUCE WU (Illumina), Director, Global Intellectual Property
  • TRAVIS YOUNG (Rigel Pharmaceuticals, Inc.), Executive Director, Intellectual Property
  • WILLIAM YOUNGBLOOD (Mylan), Assistant General Counsel, Global Intellectual Property

Forum Chair

  • GWILYM ATTWELL (Fish & Richardson P.C.), Principal

Download Full Agenda

Enter your information below to
receive a link in your inbox.

Topics For Discussion

  • Seeing The Forest For The Trees: Your IP Strategy As Part Of The Business
  • Global IP Strategies: Preparation, Process & Practice
  • Strategic Business Deals: Collaboration Between Commercial Legal & IP Legal
  • The Importance Of Due Diligence: Avoiding IP Risk During M&A
  • Negotiating Strategies For Successful Academic Partnerships

Venue: The Langham Huntington

1401 South Oak Knoll Avenue, Pasadena, CA 91106

Situated on 23 acres in Pasadena, this historic hotel is among California’s most prominent meeting venues.

General Sessions

Address top-of-mind issues in a conversational exchange among industry thought leaders, enabling participants to share lessons, expertise, leadership skills, and practical tools.


Engage in advanced dialogue in an informal boardroom-style setting on specific topics that are particularly suited to smaller group discussions.

Networking Meals

Participate in all meals and networking functions hosted on-site by Consero. These intimate gatherings provide countless opportunities to develop lasting business relationships.

Customized Itineraries

Meet with the most innovative service providers in the industry, one-on-one, based on your individual and departmental priorities. Our reputable partners are referred and vetted by your peers.

Chief IP Counsel?

Request an invitation to join the upcoming event.


Best-In-Class Solution Provider?

Learn more about our partnership opportunities.


Attendees Rave About Consero

  • “Great opportunity to connect with interesting people in an inspiring environment.”
    Marty W. | AM-Pharma
  • “Amazing mix of representation and topics! Loved every bit of the two days.”
    Prashant K. Bhauar | Rhizen Pharmaceuticals
  • “I very much enjoyed the interactive set-up and the insights from key people in the field.”
    Christoph Rehfuess | MagForce AG
  • “A terrific forum to discuss IP matter in an intimate atmosphere.”
    Bernd Hutter | MaphoSys AG